Developed in the United Kingdom, the COVID-19 vaccine from AstraZeneca and the University of Oxford has shown 74.6% effectiveness against the new, more contagious UK-based variant, B117, of SARS-CoV-2. The research results were published…

Johnson & Johnson (J&J) has applied for an Emergency Use Authorization (EUA)  from the United States Food and Drug Administration (FDA) for its one-shot COVID-19 vaccine, which has shown 66% efficacy in preventing moderate to severe…

Marquette University alumni Mary Ellen, MBA, and Scott Stanek, DDS, have committed more than $2 million to the college to support scholarships.

With more than 17 years in the dental field, Dimensions' Brand Ambassador Ann Cote, RDH, MSHA, has much to share with dental hygiene students.

As efforts to improve COVID-19 vaccination rates ramp up, more states are allowing oral health professionals to administer these immunizations after completing a certain amount of training. Currently, specially trained dental hygienists are…

It has been a year since the United States declared a public health emergency because of the rapid transmission of SARS-CoV-2. The US issued this declaration on February 3, 2020, three days following a similar statement made by the World…

QuietOn™ has announced a new solution for dental professionals seeking to protect their hearing.

This information is from the article When Should I Refer Patients to a Periodontist? By Timothy J. Hempton, DDS and Gayathri M. Shenoy, DMD. To read the article, click here.

Dental providers who receive incentive payments through the programs Domains, 1, 2 and 3 can continue participation through Dec. 31, 2021.

A peer-reviewed study in the highly regarded journal The Lancet found that Sputnik V, a new COVID-19 vaccine developed in Russia, was 91.6% effective in preventing infection with the novel coronavirus. The study included 22,000 subjects and…